DEBORAH PEASE: Open Payments
NPI 1487667606 · ATHENS, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,176 in 60 payments from 16 companies in 2025. Trend: 2023 $1,019 · 2024 $927 · 2025 $1,176
Food & beverage: $1,176
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 16 | $307 |
| AstraZeneca Pharmaceuticals LP | 4 | $148 |
| Abbott Laboratories | 9 | $147 |
| GlaxoSmithKline, LLC. | 9 | $136 |
| ABBVIE INC. | 5 | $102 |
| Lundbeck LLC | 3 | $72 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $38 |
| Lilly USA, LLC | 2 | $37 |
| Esperion Therapeutics, Inc. | 2 | $36 |
| Medtronic, Inc. | 2 | $35 |
Products named: Ozempic, FREESTYLE LIBRE 3, TRELEGY ELLIPTA, Rybelsus, VRAYLAR, AIRSUPRA, JARDIANCE, FARXIGA.
Industry payments across TN — which companies pay providers there.
